Polymyalgia Rheumatica Treatment
Polymyalgia Rheumatica Treatment
is also new. It is seen almost exclusively in people of European origin. The onset begins to appear after 50 years of age and it is also twice as common in women than in men. The main characteristics are muscle pain, especially in the proximal limb regions, such as shoulders, arms, hips and thighs. Its onset is usually acute and there are some patients who can even say the exact day when the problems started.
Frequently have systemic signs such as fever and general commitment to weight loss. The rigidity of the body in the morning, is characteristic. There is an important difference in rheumatoid arthritis is morning stiffness that hands with difficulty using their hands, while in this condition the problem is in the proximal extremities. Therefore it is hard to activities such as getting out of bed, getting up from a chair, getting into a car and even combing. Some patients report difficulty pulling sheets and blankets in the morning. All this with a relatively recent onset.
Despite this tremendous difficulty functioning and pain, the physical examination is negative. No joint inflammatory conditions. You can find some tenderness of the muscles in the proximal limb regions. Usually is not muscular atrophy. Laboratory tests are usually negative, except elevated sedimentation rate is usually over 50. Also found elevated C-reactive protein, sometimes Anemia and impaired liver function tests. It should make specific laboratory tests to rule out other rheumatic diseases.
The diagnosis is made clinically. This is a person over 50 years suddenly began to have pain and stiffness of at least two important areas such as muscles in the region of the shoulders and hips and that takes at least two weeks and the no evidence of infection or other rheumatic condition such as Rheumatoid Arthritis, Lupus or tumor. The diagnosis is confirmed one polymyalgia rheumatic treatment is if this person responds quickly to a moderate dose of corticosteroids.
The cause of this disease is unknown. Very rarely is it associated with temporal arteritis artery. This is an inflammation of the temporal artery, giant cell of undiagnosed can lead to blindness. These patients have pain in the temple area and sometimes you can see the artery that is inflamed. It is associated with headaches and pain in the jaw muscle. It is not known if these two conditions are the same disease at different developmental stages, or if in partnership, both due to a common cause such as inflammation of the arteries in the presence of giant cells.
Treatment of polymyalgia rheumatica is mainly with corticosteroids and is preferably used Medrol or prednisone. Most patients under a doctors care start with 20 mg. per day of prednisone, a single dose in the morning, for a few days and then declined to 15 mg. newspapers and whether this dose the patient reported having improved about 80 to 90% the diagnosis was confirmed. Subsequently the dose of prednisone was gradually decreased in relation to symptoms and the sedimentation rate. Treatment should usually continue for more than one to two years. The anti-inflammatory response is not as good as steroids, and these do not prevent the possibility of vascular complications such as temporal arteritis. They do not serve to confirm the diagnosis, in terms of therapeutic response. Many are known side effects of steroids in high doses (above 10 mg daily) for prolonged periods, such as osteoporosis with vertebral fractures, diabetes, ulcers with and without gastrointestinal bleeding and Waterfalls. That is why the dose should be the lowest possible dose and should be used daily in the morning.
The prognosis of this condition is generally good, provided polymyalgia rheumatica treatment is begins early. The danger lies in not making a diagnosis and develop temporal arteritis that can result in vision loss and sometimes blindness. The other danger is the possibility of side effects of steroids. On the other hand, has recently been shown that polymyalgia rheumatica is associated with cardiovascular disease, which would give a worse prognosis in this disease.
